OPL.AX A$0.022 pre-market 07 Jan 2026: Oversold bounce watch for A$0.030
OPL.AX stock trades at A$0.022 in pre-market trade on 07 Jan 2026, setting up an oversold bounce opportunity for short-term traders. Volume is muted at 76,364 versus an average of 1,073,832, increasing the risk of volatile spikes. The company, Opyl Limited (ASX: OPL), operates in the Healthcare sector in Australia and reports EPS of -0.01 and PE of -2.20. We outline triggers, price targets, technical levels, and risks for an oversold bounce strategy.
OPL.AX stock setup and price action
OPL.AX stock sits at A$0.022 with a year high of A$0.036 and a year low of A$0.014. The 50‑day average is A$0.02346 and the 200‑day average is A$0.022205, showing the price near long‑term trend support. Recent 1‑month and 5‑day moves are down 12.00%, while 3‑month is up 15.79%, highlighting choppy momentum. Low relative volume of 0.071 suggests any meaningful rebound needs confirmation by higher trade.
Fundamentals, valuation and cash metrics for OPL.AX stock
Opyl Limited is a small cap on the ASX with market cap A$5,406,896.00 and 245,768,000 shares outstanding. Trailing EPS is -0.01 and PE reads -2.20 because of negative earnings. Price‑to‑sales is high at 27.57 and book value per share is negative. The balance sheet shows cash per share 0.00193 and current ratio 0.5250, so liquidity is limited and investor risk is elevated.
Technical levels, targets and oversold bounce plan
For an oversold bounce trade, use a clear entry above A$0.024 with volume confirmation. Short‑term targets: A$0.030 (first resistance) and A$0.035 (secondary target near the year high). Suggested stop is A$0.018 to limit downside. Watch the 50‑day at A$0.02346 and the year high A$0.036 for profit taking. Keep position sizes small given high volatility and low average volume.
Meyka AI grade and technical analysis for OPL.AX stock
Meyka AI rates OPL.AX with a score out of 100: 75 out of 100 (B+) — BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Technical indicators show price near long‑term averages and a short window for a bounce. Note: independent company ratings show a mixed view, so our grade balances upside potential with financial weakness.
Catalysts, sector context and key risks for OPL.AX stock
Catalysts that could spark a bounce include positive trial recruitment updates, new client wins, or higher‑than‑expected revenue. The Healthcare sector on ASX is trading stronger than small caps overall, but Opyl is a tiny player with three full‑time staff and narrow revenue. Key risks: negative earnings, tight liquidity, and average payables of 244,632.00 that can pressure cash flows. Monitor company news and filings closely via official channels.
Where to check filings and company updates for OPL.AX stock
Use the company website and ASX for announcements before trading a bounce. Official pages: Opyl website and ASX company page for OPL. Confirm any management commentary, earnings dates, or contract news before opening positions.
Final Thoughts
Key takeaways for OPL.AX stock: the current pre‑market price A$0.022 puts the share near recent lows and within a classic oversold bounce range. Meyka AI’s model shows mixed signals: our grade is 75/100 (B+) — BUY, but Meyka AI’s forecast model projects A$0.00947 for the yearly horizon, implying -56.99% from the current price. That divergence reflects the company’s weak fundamentals and small market cap versus short‑term technical bounce potential. For traders, an aggressive short‑term plan targets A$0.030 and A$0.035 with a strict stop at A$0.018. For investors, the negative EPS, limited cash cushion, and low liquidity argue for caution. All forecasts are model‑based projections and not guarantees. Use Meyka AI‑powered market analysis and ASX filings to confirm catalysts before trading.
FAQs
OPL.AX stock trades at **A$0.022** pre‑market. Day low and high are both **A$0.022** in the current session, reflecting very thin pre‑market activity.
For an oversold bounce, watch **A$0.030** as the first target and **A$0.035** as a secondary target. Use **A$0.018** as a stop to control downside risk.
Meyka AI rates OPL.AX with a score out of 100 at **75** (Grade **B+** — **BUY**). The grade balances benchmark, sector, growth, metrics, and consensus. Grades are informational, not financial advice.
Important ratios: EPS **-0.01**, PE **-2.20**, price‑to‑sales **27.57**, current ratio **0.5250**, and negative book value. These show weak profitability and thin liquidity.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
